Let's not forget their very profitable exit stage left in 2022 either @ 75 cents
You would think that with the expertise and the contacts of the Mesoblast management team that they would be able to come up with an alternative at this stage of the game / progress in the last 6 months ..... I guess we will see in the coming weeks or shortly (sorry I couldn't resist those quotes)
GLTAH
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection, page-219
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
-0.010(1.03%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 95.0¢ | $2.617M | 2.715M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 107932 | 95.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 34142 | 1 |
View Market Depth
| Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |